Villgro Africa is inviting applications from invention-based MedTech startups across East Africa for its 24-month MedTech Innovation Program. The initiative is designed to help locally led companies strengthen product development, clinical and regulatory readiness, manufacturing capabilities, business models, and market access. The program will select six enterprises from Kenya, Uganda, Tanzania, Rwanda, Burundi, and Ethiopia. Eligible applicants should already have a functional proof of concept or prototype and be progressing through validation, pre-commercial, or early-market development.
Who Can Apply?
The program is open to tech-enabled, invention-based MedTech companies that:
- Are headquartered in, incorporated in, or primarily operating from Kenya, Uganda, Tanzania, Rwanda, Burundi, or Ethiopia.
- Have a committed East African founding team with clear technical and business leadership.
- Have at least a functional proof of concept or prototype.
- Are developing a differentiated medical product or technology with a clear healthcare use case.
- Have engaged relevant users or stakeholders such as healthcare professionals, patients, facilities, payers, or partners.
- Can clearly explain their product ownership, intellectual property, technical development status, and regulatory pathway.
- Are willing to provide technical, clinical, regulatory, financial, and corporate information during due diligence.
Companies that are still completing incorporation may apply but must be formally registered before onboarding.
Target Startup Stage
Pre-seed, Seed, Pre-series A
The strongest fit is for startups at prototype, validation, pre-commercial, or early-market stage, particularly those operating around Technology Readiness Levels 4–8. Idea-stage companies without a tangible proof of concept are not eligible.
Target Sector
Health & Life Sciences
Eligible technologies include medical devices, diagnostics, maternal and child health technologies, assistive and rehabilitation technologies, disease and critical-care solutions, connected medical technologies, AI-enabled medical products, medical manufacturing technologies, and climate-smart MedTech.
What Support Is Provided?
Selected startups will receive 24 months of tailored venture and technical support, which may include:
- Product development, testing, verification, and validation.
- Clinical, regulatory, and quality-readiness support.
- Manufacturing and scale-up planning.
- Market validation, pricing, procurement, distribution, and partnerships.
- Investment-readiness support, including milestones, capital requirements, data rooms, and pitch refinement.
- Guidance on responsible growth, environmental impact, data governance, inclusion, and product end-of-life.
Program Category
Accelerator, Funding
The program combines structured venture-building and technical acceleration support with investment-readiness assistance and potential connections to funders and partners.
Application Assessment
Applications may be assessed based on:
- Health need and potential impact.
- Strength and differentiation of the invention.
- Technical feasibility and product maturity.
- Clinical, regulatory, and user readiness.
- Team capability.
- Market and adoption potential.
- Manufacturing and scalability.
- Inclusion, responsible innovation, and environmental considerations.
Required Application Materials
Applicants may be asked to provide:
- A completed online application.
- A pitch deck of up to 15 slides.
- A product brief and development roadmap.
- Evidence of prototype testing, user research, pilot activity, or early traction where applicable.
- Regulatory, clinical, quality, and intellectual-property information.
- Business model, target market, pricing, manufacturing or delivery approach, and partnerships.
- Company registration and founder/shareholding information where available.
- Management accounts or financial statements.
- Funding history and expected capital requirements.
- A product demonstration video or link, where available.
Application Process
Applications are first screened for eligibility and completeness. Eligible companies may then undergo technical, business, regulatory, and impact review. Shortlisted teams may be invited to interviews, product demonstrations, and due diligence before the final selection is made.
Key Details
- Program: Villgro Africa MedTech Innovation Program
- Organizer: Villgro Africa
- Region: East Africa
- Eligible Countries: Kenya, Uganda, Tanzania, Rwanda, Burundi, Ethiopia
- Target Sector: Health & Life Sciences
- Target Stage: Pre-seed, Seed, Pre-series A
- Category: Accelerator, Funding
- Selected Enterprises: 6
- Support Period: 24 months
- Application Deadline: 30 September 2026
The Villgro Africa MedTech Innovation Program is aimed at East African startups that have already moved beyond the idea stage and are developing tangible medical technologies with the potential to progress toward regulatory approval, manufacturing, commercialization, and health-system adoption.